Literature DB >> 28686297

Multifaceted death receptor 3 signaling-promoting survival and triggering death.

Sebastian Bittner1, Martin Ehrenschwender1.   

Abstract

Death Receptor 3 (DR3) and its cognate ligand TL1A belong to the tumor necrosis factor superfamily (TNFSF). This sophisticated network of receptor-ligand systems controls innumerable biological processes. For many (if not all) TNFSF ligands and receptors, a role in conditions such as inflammation, tissue development, proliferation, and cell death has been firmly established. However, relatively little is known about DR3 and TL1A. Here, we review novel aspects of DR3 signaling and DR3-associated signaling pathways before summarizing the function of DR3 in the immune system. The emerging role of DR3 in disease will be addressed before we finally critically discuss the potential therapeutic exploitation of this receptor-ligand pair.
© 2017 Federation of European Biochemical Societies.

Entities:  

Keywords:  DR3; TL1A; TNFRSF25

Mesh:

Substances:

Year:  2017        PMID: 28686297     DOI: 10.1002/1873-3468.12747

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

Review 1.  Insights into the biology and therapeutic implications of TNF and regulatory T cells.

Authors:  Benoit L Salomon
Journal:  Nat Rev Rheumatol       Date:  2021-07-05       Impact factor: 20.543

Review 2.  Analysis of therapeutic potential of preclinical models based on DR3/TL1A pathway modulation (Review).

Authors:  Yunhong Yu; Peng Jiang; Pan Sun; Na Su; Fangzhao Lin
Journal:  Exp Ther Med       Date:  2021-05-02       Impact factor: 2.447

3.  An anti-TL1A antibody for the treatment of asthma and inflammatory bowel disease.

Authors:  Adam W Clarke; Lynn Poulton; Doris Shim; David Mabon; Danyal Butt; Matthew Pollard; Vanya Pande; Jean Husten; Jacquelyn Lyons; Chen Tian; Anthony G Doyle
Journal:  MAbs       Date:  2018-03-05       Impact factor: 5.857

4.  Tumor necrosis factor receptor family costimulation increases regulatory T-cell activation and function via NF-κB.

Authors:  Martina Lubrano di Ricco; Emilie Ronin; Davi Collares; Jordane Divoux; Sylvie Grégoire; Harald Wajant; Tomás Gomes; Yenkel Grinberg-Bleyer; Véronique Baud; Gilles Marodon; Benoît L Salomon
Journal:  Eur J Immunol       Date:  2020-02-19       Impact factor: 5.532

5.  DR3 and its ligands take roles in periodontium remodeling during orthodontic tooth movement.

Authors:  Chuanliang Ling; Ruolin Cai; Yiming Gong; Xiaojun Ding
Journal:  J Dent Sci       Date:  2020-03-19       Impact factor: 2.080

6.  Roles for ADAM17 in TNF-R1 Mediated Cell Death and Survival in Human U937 and Jurkat Cells.

Authors:  Jürgen Fritsch; Julia Frankenheim; Lothar Marischen; Timea Vadasz; Anja Troeger; Stefan Rose-John; Dirk Schmidt-Arras; Wulf Schneider-Brachert
Journal:  Cells       Date:  2021-11-10       Impact factor: 6.600

Review 7.  Role of TL1A in Inflammatory Autoimmune Diseases: A Comprehensive Review.

Authors:  Wang-Dong Xu; Rong Li; An-Fang Huang
Journal:  Front Immunol       Date:  2022-07-14       Impact factor: 8.786

8.  Biosensors for inflammation as a strategy to engineer regulatory T cells for cell therapy.

Authors:  Sebastian Bittner; Brigitte Ruhland; Veronika Hofmann; Lisa Schmidleithner; Kathrin Schambeck; Asmita Pant; Philipp Stüve; Michael Delacher; Bernd Echtenacher; Matthias Edinger; Petra Hoffmann; Michael Rehli; Claudia Gebhard; Nicholas Strieder; Thomas Hehlgans; Markus Feuerer
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-26       Impact factor: 12.779

Review 9.  Novel Insights on the Regulation of B Cell Functionality by Members of the Tumor Necrosis Factor Superfamily in Jawed Fish.

Authors:  Carolina Tafalla; Aitor G Granja
Journal:  Front Immunol       Date:  2018-06-07       Impact factor: 7.561

10.  TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell Responses.

Authors:  Bruna Oriol-Tordera; Alex Olvera; Clara Duran-Castells; Anuska Llano; Beatriz Mothe; Marta Massanella; Judith Dalmau; Carmela Ganoza; Jorge Sanchez; Maria Luz Calle; Bonaventura Clotet; Javier Martinez-Picado; Eugènia Negredo; Julià Blanco; Dennis Hartigan-O'Connor; Christian Brander; Marta Ruiz-Riol
Journal:  J Immunol       Date:  2020-11-11       Impact factor: 5.422

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.